Structural modification of siRNA for efficient gene silencing

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 491-503

  Lee, So Jin ^a   Son, Sejin ^a   Yhee, Ji Young ^a   Choi, Kuiwon ^a   Kwon, Ick Chan ^a   Kim, Sun Hwa ^a   Kim, Kwangmeyung ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Polyplexes; RNAi; SiRNA; SiRNA delivery; Structured siRNA

Indexed keywords

POLYPLEXES; RNAI; SIRNA; SIRNA DELIVERY; STRUCTURED SIRNA;

CHARGE DENSITY; CHEMICAL PROPERTIES; DYES; EFFICIENCY; GENETIC ENGINEERING; POLYMERS; SURFACE PROPERTIES;

RNA;

NANOPARTICLE; SMALL INTERFERING RNA;

CATION; CONDENSATION; DISEASE TREATMENT; GENETIC ENGINEERING; GENOMICS; PHYSICOCHEMICAL PROPERTY; POLYMER; POLYMERIZATION; RNA; SERUM;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE SILENCING; GENETICS; HUMAN; REVIEW; RNA INTERFERENCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE SILENCING; HUMANS; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84879411641     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.09.002     Document Type: Review

References (74)

1. Akita H., Harashima H. Advances in non-viral gene delivery: using multifunctional envelope-type nano-device. Expert Opin Drug Deliv 2008, 5:847-859.
2. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008, 5:505-515.
3. Bartlett D.W., Su H., Hildebrandt I.J., Weber W.A., Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A 2007, 104:15549-15554.
4. Beissenhirtz M.K., Willner I. DNA-based machines. Org Biomol Chem 2006, 4:3392-3401.
5. Bhatia D., Surana S., Chakraborty S., Koushika S.P., Krishnan Y. A synthetic icosahedral DNA-based host-cargo complex for functional in vivo imaging. Nat Commun 2011, 2:339.
6. Bolcato-Bellemin A.L., Bonnet M.E., Creusatt G., Erbacher P., Behr J.P. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci U S A 2007, 104:16050-16055.
7. Breunig M., Lungwitz U., Liebl R., Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci U S A 2007, 104:14454-14459.
8. Bumcrot D., Manoharan M., Koteliansky V., Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2006, 2:711-719.
9. Burnett J.C., Rossi J.J., Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J 2011, 6:1130-1146.
10. Choi H.S., Liu W., Liu F., Nasr K., Misra P., Bawendi M.G., et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol 2010, 5:42-47.
11. Choung S., Kim Y.J., Kim S., Park H.O., Choi Y.C. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 2006, 342:919-927.
12. Chung H.J., Hong C.A., Lee S.H., Jo S.D., Park T.G. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing. Bioconjug Chem 2011, 22:299-306.
13. Creusat G., Rinaldi A.S., Weiss E., Elbaghdadi R., Remy J.S., Mulherkar R., et al. Proton sponge trick for ph-sensitive disassembly of polyethylenimine-based siRNA delivery systems. Bioconjug Chem 2010, 21:994-1002.
14. Crooke S.T. Vitravene (TM) - another piece in the mosaic. Antisense Nucleic A 1998, 8:Vii-Viii.
15. Daubendiek S.L., Ryan K., Kool E.T. Rolling-circle RNA-synthesis - circular oligonucleotides as efficient substrates for T7 RNA-polymerase. J Am Chem Soc 1995, 117:7818-7819.
16. Davidson B.L., McCray P.B. Current prospects for RNA interference-based therapies. Nat Rev Genet 2011, 12:329-340.
17. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
18. Dykxhoorn D.M., Lieberman J. Running interference: Prospects and obstacles to using small interfering RNAs as small molecule drugs. Annu Rev Biomed Eng 2006, 8:377-402.
19. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
20. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 1998, 391:806-811.
21. Gaglione M., Messere A. Recent progress in chemically modified siRNAs. Mini Rev Med Chem 2010, 10:578-595.
22. Gindy M.E., Prud'homme R.K. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 2009, 6:865-878.
23. Guo J.F., Bourre L., Soden D.M., O'Sullivan G.C., O'Driscoll C. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?. Biotechnol Adv 2011, 29:402-417.
24. Hong C.A., Lee S.H., Kim J.S., Park J.W., Bae K.H., Mok H., et al. Gene silencing by siRNA microhydrogels via polymeric nanoscale condensation. J Am Chem Soc 2011, 133:13914-13917.
25. Huang L., Liu Y. In vivo delivery of rnai with lipid-based nanoparticles. Annu Rev Biomed Eng 2011, 13:507-530.
26. Jackson A.L., Burchard J., Leake D., Reynolds A., Schelter J., Guo J., et al. Position-specific chemical modification of siRNAs reduces "off-target'" transcript silencing. RNA 2006, 12:1197-1205.
27. John M., Constien R., Akinc A., Goldberg M., Moon Y.A., Spranger M., et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 2007, 449:745-U12.
28. Kim W.J., Kim S.W. Efficient siRNA Delivery with Non-viral Polymeric Vehicles. Pharm Res Dord 2009, 26:657-666.
29. Kole R., Krainer A.R., Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 2012, 11:125-140.
30. Koo H., Huh M.S., Sun I.C., Yuk S.H., Choi K., Kim K., et al. In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 2011, 44:1018-1028.
31. Lee S.Y., Huh M.S., Lee S., Lee S.J., Chung H., Park J.H., et al. Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J Control Release 2010, 141:339-346.
32. Lee H., Lytton-Jean A.K.R., Chen Y., Love K.T., Park A.I., Karagiannis E.D., et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol 2012, 7:389-393.
33. Lee J.B., Hong J., Bonner D.K., Poon Z., Hammond P.T. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nat Mater 2012, 11:316-322.
34. Lee S.H., Chung B.H., Park T.G., Nam Y.S., Mok H. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing. Acc Chem Res 2012, 45:1014-1025.
35. Lee S.J., Huh M.S., Lee S.Y., Min S., Lee S., Koo H., et al. Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic sirna delivery in cancer treatment. Angew Chem Int Ed Engl 2012, 51:7203-7207.
36. Lemkine G.F., Demeneix B.A. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 2001, 3:178-182.
37. Li B.J., Tang Q.Q., Cheng D., Qin C., Xie F.Y., Wei Q., et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque. Nat Med 2005, 11:944-951.
38. Lin C., Zhong Z., Lok M.C., Jiang X., Hennink W.E., Feijen J., et al. Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release 2006, 116:130-137.
39. Liu H., Liu D.S. DNA nanomachines and their functional evolution. Chem Commun 2009, 2625-2636.
40. Mastrobattista E., Hennink W.E. Polymers for gene delivery charged for success. Nat Mater 2012, 11:10-12.
41. Melancon M.P., Lu W., Li C. Gold-based magneto/optical nanostructures: challenges for in vivo applications in cancer diagnostics and therapy. MRS Bull 2009, 34:415-421.
42. Meyer M., Dohmen C., Philipp A., Kiener D., Maiwald G., Scheu C., et al. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol Pharm 2009, 6:752-762.
43. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2009, 109:259-302.
44. Modi S., Swetha M.G., Goswami D., Gupta G.D., Mayor S., Krishnan Y. A DNA nanomachine that maps spatial and temporal pH changes inside living cells. Nat Nanotechnol 2009, 4:325-330.
45. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
46. Mok H., Lee S.H., Park J.W., Park T.G. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat Mater 2010, 9:272-278.
47. Moshfeghi A.A., Puliafito C.A. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs 2005, 14:671-682.
48. Napoli C., Lemieux C., Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990, 2:279-289.
49. Oh Y.K., Park T.G. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009, 61:850-862.
50. Peacock H., Kannan A., Beal P.A., Burrows C.J. Chemical modification of siRNA bases to probe and enhance RNA interference. J Org Chem 2011, 76:7295-7300.
51. Peng Q., Zhong Z., Zhuo R. Disulfide cross-linked polyethylenimines (PEI) prepared via thiolation of low molecular weight PEI as highly efficient gene vectors. Bioconjug Chem 2008, 19:499-506.
52. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010, 9:615-627.
53. Philipp A., Zhao X.B., Tarcha P., Wagner E., Zintchenko A. Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. Bioconjug Chem 2009, 20:2055-2061.
54. Piest M., Engbersen J.F.J. Effects of charge density and hydrophobicity of poly(amido amine)s for non-viral gene delivery. J Control Release 2010, 148:83-90.
55. Rose S.D., Kim D.H., Amarzguioui M., Heidel J.D., Collingwood M.A., Davis M.E., et al. Functional polarity is introduced by Dicer processing of short substrate RNAs. Nucleic Acids Res 2005, 33:4140-4156.
56. Roush W. Antisense aims for a renaissance. Science 1997, 276:1192-1193.
57. Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., et al. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 2007, 104:12982-12987.
58. Saranya N., Moorthi A., Saravanan S., Devi M.P., Selvamurugan N. Chitosan and its derivatives for gene delivery. Int J Biol Macromol 2011, 48:234-238.
59. Seth S., Johns R., Templin M.V. Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects. Ther Deliv 2012, 3:245-261.
60. Seyhan A.A., Vlassov A.V., Johnston B.H. RNA interference from multimeric shRNAs generated by rolling circle transcription. Oligonucleotides 2006, 16:353-363.
61. Shukla S., Sumaria C.S., Pradeepkumar P.I. Exploring chemical modifications for sirna therapeutics: a structural and functional outlook. ChemMedChem 2010, 5:328-349.
62. Singha K., Namgung R., Kim W.J. Polymers in small-interfering RNA delivery. Nucleic Acid Ther 2011, 21:133-147.
63. Son S., Kim W.J. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials 2010, 31:133-143.
64. Son S., Singha K., Kim W.J. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials 2010, 31:6344-6354.
65. Son S., Hwang D.W., Singha K., Jeong J.H., Park T.G., Lee D.S., et al. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J Control Release 2011, 155:18-25.
66. Tan S.J., Kiatwuthinon P., Roh Y.H., Kahn J.S., Luo D. Engineering nanocarriers for siRNA delivery. Small 2011, 7:841-856.
67. Wagner E. Polymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise. Acc Chem Res 2012, 45:1005-1013.
68. Walsh A.S., Yin H., Erben C.M., Wood M.J., Turberfield A.J. DNA cage delivery to mammalian cells. ACS Nano 2011, 5:5427-5432.
69. Walton S.P., Wu M., Gredell J.A., Chan C. Designing highly active siRNAs for therapeutic applications. FEBS J 2010, 277:4806-4813.
70. Watts J.K., Corey D.R. Clinical status of duplex RNA. Bioorg Med Chem Lett 2010, 20:3203-3207.
71. Weissleder R., Kelly K., Sun E.Y., Shtatland T., Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005, 23:1418-1423.
72. Zhang H.D., Kolb F.A., Brondani V., Billy E., Filipowicz W. Human dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002, 21:5875-5885.
73. Zintchenko A., Philipp A., Dehshahri A., Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem 2008, 19:1448-1455.
74. Zou S.M., Erbacher P., Remy J.S., Behr J.P. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2000, 2:128-134.